Anthony S. Marucci, President & CEO at Celldex Therapeutics, Inc. (CLDX), bought 11,900 shares at $3.46 ($41K) on 2010-09-10, disclosed to the SEC on 2010-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.41 | 2,300 | $8K | 19.1% |
| 2 | $3.41 | 200 | $682 | 1.7% |
| 3 | $3.43 | 2,500 | $9K | 20.9% |
| 4 | $3.46 | 300 | $1K | 2.5% |
| 5 | $3.46 | 319 | $1K | 2.7% |
| 6 | $3.46 | 181 |
| $626 |
| 1.5% |
| 7 | $3.46 | 200 | $692 | 1.7% |
| 8 | $3.46 | 500 | $2K | 4.2% |
| 9 | $3.46 | 1,400 | $5K | 11.8% |
| 10 | $3.47 | 200 | $694 | 1.7% |
| 11 | $3.48 | 200 | $696 | 1.7% |
| 12 | $3.48 | 1,500 | $5K | 12.7% |
| 13 | $3.48 | 1,600 | $6K | 13.6% |
| 14 | $3.48 | 100 | $348 | 0.8% |
| 15 | $3.48 | 400 | $1K | 3.4% |
| Total | $3.45 avg | 11,900 | $41K | 100% |
| Filing → |
| CLDX | BUY | 2020-06-10 | $46K | — | Filing → |
| CLDX | BUY | 2015-08-14 | $97K | — | Filing → |
| CLDX | BUY | 2011-08-10 | $36K | — | Filing → |